Inaugural Pharmacogenomics Access and Reimbursement Symposium.
Congresses as Topic
/ trends
District of Columbia
Health Personnel
/ economics
Health Services Accessibility
/ economics
Humans
Insurance, Health, Reimbursement
/ economics
Medical Assistance
/ economics
Pharmacogenetics
/ economics
Precision Medicine
/ economics
Technology Assessment, Biomedical
/ economics
COVID-19
health economics
health policy
health technology assessment
innovation
patient access
payment models
pharmacogenetics testing
pharmacogenomics
precision medicine
reimbursement
Journal
Pharmacogenomics
ISSN: 1744-8042
Titre abrégé: Pharmacogenomics
Pays: England
ID NLM: 100897350
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
pubmed:
26
5
2021
medline:
30
6
2021
entrez:
25
5
2021
Statut:
ppublish
Résumé
The Pharmacogenomics Access & Reimbursement Symposium, a landmark event presented by the Golden Helix Foundation and the Pharmacogenomics Access & Reimbursement Coalition, was a 1-day interactive meeting comprised of plenary keynotes from thought leaders across healthcare that focused on value-based strategies to improve patient access to personalized medicine. Stakeholders including patients, healthcare providers, industry, government agencies, payer organizations, health systems and health policy organizations convened to define opportunities to improve patient access to personalized medicine through best practices, successful reimbursement models, high quality economic evaluations and strategic alignment. Session topics included health technology assessment, health economics, health policy and value-based payment models and innovation.
Identifiants
pubmed: 34032472
doi: 10.2217/pgs-2021-0016
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM